Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy

Diabetologia

Volumn 48, Issue 8, 2005, Pages 1637-1644

  Meerwaldt, R ^a   Links, T P ^a   Graaff, R ^b   Hoogenberg, K ^c   Lefrandt, J D ^a   Baynes, J W ^d   Gans, R O B ^a   Smit, A J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c MARTINI HOSPITAL   (Netherlands)

^d UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Advanced glycation end product (AGE); Autofluorescence; Autonomic; Nerve conduction; Neuropathy

Indexed keywords

ADVANCED GLYCATION END PRODUCT; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; AUTOFLUORESCENCE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BIOACCUMULATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIABETIC FOOT; DIABETIC NEUROPATHY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HEART RATE VARIABILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEDIAN NERVE; MICROALBUMINURIA; MOTOR NERVE CONDUCTION; NEUROGRAPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SELECTION; PERONEUS NERVE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SENSORY NERVE CONDUCTION; SKIN; SURAL NERVE;

AGED; ALBUMINURIA; BAROREFLEX; CROSS-SECTIONAL STUDIES; DIABETIC FOOT; DIABETIC NEUROPATHIES; FEMALE; FLUORESCENCE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEART RATE; HUMANS; MALE; MIDDLE AGED; NEURAL CONDUCTION; NEUROLOGIC EXAMINATION; PERIPHERAL NERVES; SKIN;

EID: 23844441894     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-1828-x     Document Type: Article

References (46)

1. Holzer SE, Camerota A, Martens L, Guerdon T, Crystal-Peters J, Zagari M (1998) Costs and duration of care for lower extremity ulcers in patients with diabetes. Clin Ther 20:169-181
2. Young MJ, Boulton AJM, McLeod AF, Williams DRR, Sonksen PH (1993) A multicentre study of the prevalence of diabetic neuropathy in the UK hospital clinical population. Diabetologia 36:150-154
3. Boulton AJM (1996) The pathogenesis of diabetic foot problems: an overview. Diabet Med 13:12-16
4. Ewing DJ, Campbell IW, Clarke BF (1976) Mortality in diabetic autonomic neuropathy. Lancet 1:601-603
5. Cameron NE, Eaton SE, Cotter MA, Tesfaye S (2001) Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 44:1973-1988
6. Baynes JW (2002) Glycation and advanced glycation reaction. In: Gries FA, Cameron NE, Low PA, Ziegler D (eds) Diabetic neuropathy. Thieme Medical, Stuttgart
7. Obrosova IG (2003) Update on the pathogenesis of diabetic neuropathy. Curr Diab Rep 3:439-445
8. King RH (2001) The role of glycation in the pathogenesis of diabetic polyneuropathy. Mol Pathol 54:400-408
9. Schleicher E, Wagner E, Nerlich AG (1997) Increased accumulation of the glycoxidation product Ne-(carboxymethyl) lysine in human tissues in diabetes and aging. J Clin Invest 9:457-468
10. Makita Z, Radoff S, Rayfield EJ et al (1991) Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325:836-842
11. Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications. A new perspective on an old Paradigm. Diabetes 48:1-9
12. Nishikawa T, Edelstein D, Du XL et al (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790
13. Monnier VM, Bautista O, DCCT Skin Collagen Ancillary Study Group (1999) Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes. Diabetes 48:870-880
14. Nilsson BO (1999) Biological effects of aminoguanidine: an update. Inflamm Res 48:509-515
15. Stracke H, Lindemann A, Federlin K (1996) Benfotiamin-vitamin B combination in treatment of diabetic neuropathy. Exp Clin Endocrinol Diabetes 104:311-316
16. Cameron NE, Cotter MA, Dines K, Love A (1992) Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia 35:946-950
17. Dorrian CA, Cathcart S, Clausen J, Shapiro D, Dominiczak MH (1998) Factors in human serum interfere with the measurement of advanced glycation endproducts. Cell Mol Biol 44:1069-1079
18. Meerwaldt R, Smit AJ, Navis GJ, van Roon AM, Graaff R, Gans ROB (2000) Increased skin autofluorescence in diabetes mellitus and renal failure. Diabetologia 44 [Suppl]:A1046
19. Meerwaldt R, Graaff R, Oomen PHN et al (2004) Simple noninvasive assessment of advanced glycation endproduct accumulation. Diabetologia 47:1324-1330
20. Coremans JMC, Ince C, Bruining HA, Puppels GJ (1997) (Semi-) quantitative analysis of reduced nicotinamide adenine dinucleotide fluorescence image of blood perfused rat heart. Biophys J 72:1849-1860
21. Na R, Stender IM, Henriksen M, Wulf HC (2001) Autofluorescence of human skin is age-related after correction for skin pigmentation and redness. J Invest Dermatol 116:536-540
22. Meijer JWG, van Sonderen E, Blaauwwiekel EE et al (2000) Diabetic neuropathy examination: a hierarchical scoring system to diagnose distal polyneuropathy in diabetes. Diabetes Care 23:750-753
23. Dyck PJ (1998) Detection, characterization and staging of polyneuropathy: assessed in diabetics. Muscle Nerve 11:21-32
24. Kumar S, Fernando DJS, Veves A, Knowles EA, Young MJ, Boulton AJM (1991) Semmes Weinstein mono filaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract 13:63-68
25. Young MJ, Breddy JL, Veves A, Boulton AJM (1994) The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. Diabetes Care 17:557-560
26. Task Force of the European Society of Cardiology and the Northern American Society of Pacing and Electrophysiology (1996) Heart rate variability. Standards of measurement, physiological interpretation and clinical use. Circulation 93:1043-1065
27. Lefrandt JD, Hoogenberg K, van Roon AM, Dullaart RPF, Gans ROB, Smit AJ (1999) Baroreflex sensitivity is depressed in microalbuminuric type 1 diabetic patients at rest and during sympathetic manoeuvres. Diabetologia 42:1345-1349
28. Robbe HW, Mulder LJ, Ruddel H, Langewitz WA, Veldman JB, Mulder G (1987) Assessment of baroreceptor reflex sensitivity by means of spectral analysis. Hypertension 10:538-543
29. Cerami C, Hounds H, Nicholl L et al (1997) Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci U S A 94:13915-13920
30. Nicoll ID, Stitt AW, Moore JE (1998) Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers. Mol Med 4:594-601
31. Koschinsky T, He CJ, Mitsuhashi T et al (1997) Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci USA 94:6474-6479
32. Thornalley PJ (2002) Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options. Int Rev Neurobiol 50:37-57
33. Cellek S, Qu W, Schmidt AM, Moncade S (2004) Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neural apoptosis in vitro: a new insight into selective nitregic neuropathy in diabetes. Diabetologia 47:331-339
34. Tanaka Y, Uchino H, Shimizu T et al (1999) Effect of metformin on advanced glycation endproduct formation and peripheral nerve function in streptozotocin-induced diabetic rats. Eur J Pharmacol 376:17-22
35. Baba M, Ozaki I (2001) Electrophysiological changes in diabetic neuropathy: from subclinical alterations to disabling abnormalities. Arch Physiol Biochem 109:234-240
36. Veves A, Akbari CM, Primavera J et al (1998) Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 47:457-463
37. Jude EB, Abbott CA, Young MJ, Anderson SG, Douglas JT, Boulton AJ (1999) The potential role of cell adhesion molecules in the pathogenesis of diabetic neuropathy. Diabetologia 41:330-336
38. Goova MT, Kislinger T, Qu W et al (2001) Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol 159:513-525
39. Pierce GF (2001) Inflammation in nonhealing diabetic wounds. Am J Pathol 159:399-403
40. Toyre JP, Partanen JV, Niskanen LK, Lansimies EA, Uusitupa MI (1997) Divergent development of autonomic and peripheral somatic neuropathies in NIDDM. Diabetologia 40:953-958
41. Burger AJ, Weinrauch LA, D'Elia JA, Aronson D (1999) Effect of glycemic control on heart rate variability in type 1 diabetic patients with cardiac autonomic neuropathy. Am J Cardiol 84:687-691
42. Lefrandt JD, Mulder MC, Bosma E, Smit AJ, Hoogenberg K (2001) Relation between autonomic function and blood glucose in the nondiabetic range. Diabetes Care 24:2017
43. Lefrandt JD, Mulder MC, Bosma E, Smit AJ, Hoogenberg K (2003) Inverse relationship between blood glucose and autonomic function in healthy subjects. Diabetes Care 23:1862-1864
44. Lefrandt JD, Diercks GF, van Boven AJ, Crijns HJ, van Gilst WH, Gans RO (2000) High fasting glucose and QTc duration in a large healthy cohort. Diabetologia 43:1332-1333
45. Beisswenger PJ, Makita Z, Curphey TJ et al (1995) Formation of immunochemical advanced glycosylation end products precede and correlate with early manifestations of renal and retinal disease in diabetes. Diabetes 44:824-829
46. Baynes JW, Thorpe SR (2000) Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 28:1708-1716